Enright Siobhan, Varadkar Sonia, Demaio Alison, Flynn Catherine, Ni Áinle Fionnuala, Hehir Mark P
Rotunda Hospital, Parnell Square, Dublin 1, Ireland.
Coombe Women and Infants University Hospital, Cork St., Merchants Quay, Dublin 8, Ireland.
J Perinat Med. 2019 Feb 25;47(2):195-199. doi: 10.1515/jpm-2018-0227.
Background Hemorrhage is a critical contributor to maternal morbidity but estimation of blood loss at delivery is frequently inaccurate. Due to this inaccuracy we sought to examine blood transfusion as a surrogate marker for morbidity in a large non-population based consecutive cohort. Methods A retrospective analysis of prospectively gathered data was carried out at two university institutions serving a heterogeneous urban obstetric population from January to December 2016. Data were analyzed to determine whether individual characteristics were associated with perinatal transfusion. Hematological indices and requirement for other blood products were also characterized. Results A total of 16,581 deliveries were recorded during the study and 1.7% (289/16,581) of the cohort required red cell transfusion. Those who received transfusion were more likely to be nulliparous, and to deliver <37 weeks' or >42 weeks' gestation. They were also more likely to have a macrosomic infant (birthweight >4 kg) and to have had a multiple pregnancy. Characteristics not associated with risk of transfusion included obesity [18% (52/289) vs. 15% (2445/16,292); P=0.18], and maternal age ≥35 years [28% (82/289) vs. 33% (5537/16,292); P=0.05]. Additional blood products were necessary in a small number of patients who received red cells. Conclusion The rate of transfusion in a contemporary Irish cohort has risen compared with previous data. Several variables associated with transfusion are consistent with older studies but importantly; maternal obesity and advanced maternal age are not associated with transfusion. These data may encourage the investment of resources in a population previously considered low-risk and, following future studies, to improve strategies aimed at limiting blood transfusion.
出血是导致孕产妇发病的关键因素,但分娩时失血量的估计往往不准确。由于这种不准确性,我们试图在一个大型非基于人群的连续队列中,将输血作为发病的替代指标进行研究。
对2016年1月至12月在两所大学机构收集的前瞻性数据进行回顾性分析,这些机构服务于异质的城市产科人群。分析数据以确定个体特征是否与围产期输血相关。还对血液学指标和其他血液制品的需求进行了特征描述。
研究期间共记录了16581例分娩,队列中的1.7%(289/16581)需要红细胞输血。接受输血的产妇更可能是初产妇,且分娩孕周小于37周或大于42周。她们也更可能有巨大儿(出生体重>4kg)和多胎妊娠。与输血风险无关的特征包括肥胖[18%(52/289)对15%(2445/16292);P=0.18]和产妇年龄≥35岁[28%(82/289)对33%(5537/16292);P=0.05]。少数接受红细胞输血的患者还需要其他血液制品。
与先前数据相比,当代爱尔兰队列中的输血率有所上升。一些与输血相关的变量与既往研究一致,但重要的是,产妇肥胖和高龄产妇与输血无关。这些数据可能会促使在以前被认为是低风险的人群中投入资源,并在未来研究之后,改进旨在限制输血的策略。